NUP43

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, NUP43 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated NUP43 data layer compared with 25 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher NUP43 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated NUP43 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.

HNSC, LUAD, and CCRCC are the cancer types where NUP43 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCDFSMedianIII,IV0.7610.462<.00155view →
LUADOSTertileAll0.9600.772.00820view →
CCRCCOSMedianIII,IV0.5650.889.00216view →
GBMDFSTertileAll0.4830.332.0395view →
UCECOSQuartileII,III,IV0.5581.000.0384view →
PDACDFSQuartileII,III,IV0.4480.267.0392view →
Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

NUP43–HNSC (DFS)

Kaplan–Meier survival curve for NUP43 mass-spec protein-high vs -low samples in HNSC.

Open the HNSC breakdown →

Exploration